195 related articles for article (PubMed ID: 32816597)
1. The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle.
Adhikari A; Davie JK
Cell Cycle; 2020 Sep; 19(18):2373-2394. PubMed ID: 32816597
[TBL] [Abstract][Full Text] [Related]
2. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.
Adhikari A; Mainali P; Davie JK
J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284
[TBL] [Abstract][Full Text] [Related]
3. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
4. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
Mu W; Starmer J; Yee D; Magnuson T
Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1.
Pozner A; Terooatea TW; Buck-Koehntop BA
J Biol Chem; 2016 Nov; 291(47):24538-24550. PubMed ID: 27694442
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit.
Blais A; van Oevelen CJ; Margueron R; Acosta-Alvear D; Dynlacht BD
J Cell Biol; 2007 Dec; 179(7):1399-412. PubMed ID: 18166651
[TBL] [Abstract][Full Text] [Related]
7. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response.
Turgeon N; Blais M; Delabre JF; Asselin C
J Cell Biochem; 2013 May; 114(5):1203-15. PubMed ID: 23192652
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
9. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
10. EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.
Liu T; Hou L; Huang Y
Tumour Biol; 2014 Jul; 35(7):7239-47. PubMed ID: 24771265
[TBL] [Abstract][Full Text] [Related]
11. Polycomb repressive complex 2 regulates normal development of the mouse heart.
He A; Ma Q; Cao J; von Gise A; Zhou P; Xie H; Zhang B; Hsing M; Christodoulou DC; Cahan P; Daley GQ; Kong SW; Orkin SH; Seidman CE; Seidman JG; Pu WT
Circ Res; 2012 Feb; 110(3):406-15. PubMed ID: 22158708
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
[TBL] [Abstract][Full Text] [Related]
13. EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
Yan J; Ng SB; Tay JL; Lin B; Koh TL; Tan J; Selvarajan V; Liu SC; Bi C; Wang S; Choo SN; Shimizu N; Huang G; Yu Q; Chng WJ
Blood; 2013 May; 121(22):4512-20. PubMed ID: 23529930
[TBL] [Abstract][Full Text] [Related]
14. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.
Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M
J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391
[TBL] [Abstract][Full Text] [Related]
15. EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.
Hübner JM; Müller T; Papageorgiou DN; Mauermann M; Krijgsveld J; Russell RB; Ellison DW; Pfister SM; Pajtler KW; Kool M
Neuro Oncol; 2019 Jul; 21(7):878-889. PubMed ID: 30923826
[TBL] [Abstract][Full Text] [Related]
16. Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38α activation.
Consalvi S; Brancaccio A; Dall'Agnese A; Puri PL; Palacios D
Nat Commun; 2017 Jan; 8():13956. PubMed ID: 28067271
[TBL] [Abstract][Full Text] [Related]
17. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
18. A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis.
Guo P; Lim RC; Rajawasam K; Trinh T; Sun H; Zhang H
Elife; 2024 Feb; 13():. PubMed ID: 38346162
[TBL] [Abstract][Full Text] [Related]
19. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]